Exact Mass: 638.4393602

Exact Mass Matches: 638.4393602

Found 371 metabolites which its exact mass value is equals to given mass value 638.4393602, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ginsenoside F1

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol

C36H62O9 (638.4393602)


Ginsenoside F1 is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite and an apoptosis inhibitor. It is a 12beta-hydroxy steroid, a 3beta-hydroxy steroid, a beta-D-glucoside, a ginsenoside, a tetracyclic triterpenoid, a 6alpha-hydroxy steroid and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane. Ginsenoside F1 is a natural product found in Panax ginseng, Panax notoginseng, and Gynostemma yixingense with data available. Ginsenoside F1 is found in tea. Ginsenoside F1 is isolated from Panax species. Isolated from Panax subspecies Ginsenoside F1 is found in tea. Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity. Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity.

   

Sanchinoside B2

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-oxidanyl-hept-5-en-2-yl]-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]oxane-3,4,5-

C36H62O9 (638.4393602)


(20S)-ginsenoside Rh1 is a tetracyclic triterpenoid that is (20S)-protopanaxadiol which is substituted by beta-D-glucoside at the 6alpha position. It has a role as a plant metabolite. It is a beta-D-glucoside, a 12beta-hydroxy steroid, a tetracyclic triterpenoid, a ginsenoside, a 3beta-hydroxy steroid and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane. Ginsenoside Rh1 is a natural product found in Panax vietnamensis, Panax ginseng, and other organisms with data available. A tetracyclic triterpenoid that is (20S)-protopanaxadiol which is substituted by beta-D-glucoside at the 6alpha position. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.

   

Bullatanocin

3-[9-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)-2-hydroxynonyl]-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


12,15-cis-Sylvaticin is found in alcoholic beverages. 12,15-cis-Sylvaticin is isolated from Rollinia mucosa (biriba).

   

Mogroside IE

(2R,3R,4S,5S,6R)-2-(((3S,8S,9R,10R,11R,13R,14S,17R)-17-((2R,5R)-5,6-Dihydroxy-6-methylheptan-2-yl)-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C36H62O9 (638.4393602)


Mogroside IE is a mogroside that is mogrol in which the hydroxyl hydrogen at position 3 has been replaced by a beta-D-glucosyl residue. It has a role as a plant metabolite. It is a mogroside, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a mogrol. A mogroside that is mogrol in which the hydroxyl hydrogen at position 3 has been replaced by a beta-D-glucosyl residue. Mogroside I-E1. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=88901-39-7 (retrieved 2024-08-14) (CAS RN: 88901-39-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Ginsenoside Rh1

(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O9 (638.4393602)


CID 12855917 is a natural product found in Panax ginseng, Panax notoginseng, and other organisms with data available. Ginsenoside Rh1 is found in tea. Ginsenoside Rh1 is isolated from Panax species. Isolated from Panax subspecies Ginsenoside Rh1 is found in tea. (20R)-Ginsenoside Rh1, the R isomer of Ginsenoside Rh1 isolated from Panax Ginseng, inhibits the thrombin-induced conversion of fibrinogen to fibrin[1]. (20R)-Ginsenoside Rh1, the R isomer of Ginsenoside Rh1 isolated from Panax Ginseng, inhibits the thrombin-induced conversion of fibrinogen to fibrin[1]. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.

   

12,15-cis-Squamostatin A

3-[9-(5-{4-[5-(1,5-dihydroxyundecyl)oxolan-2-yl]-1,4-dihydroxybutyl}oxolan-2-yl)nonyl]-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Constituent of the seeds of Annona atemoya (custard apple). Cytotoxic. 12,15-cis-Squamostatin A is found in fruits. Squamostatin B is found in fruits. Squamostatin B is a constituent of Annona squamosa (sugar apple).

   

27-Hydroxybullatacin

3-(13-{5-[5-(1,4-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}-2,13-dihydroxytridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


27-Hydroxybullatacin is found in alcoholic beverages. 27-Hydroxybullatacin is a constituent of Annona glabra (pond apple) Constituent of Annona glabra (pond apple). 27-Hydroxybullatacin is found in alcoholic beverages and fruits.

   

20,23-cis-Bullatalicinone

5-[7-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)heptyl]-3-(2-oxopropyl)oxolan-2-one

C37H66O8 (638.4757436)


20,23-cis-Bullatalicinone is found in alcoholic beverages. 20,23-cis-Bullatalicinone is a constituent of unripe fruit of Rollinia mucosa (biriba) Constituent of unripe fruit of Rollinia mucosa (biriba). 20,23-cis-Bullatalicinone is found in alcoholic beverages and fruits.

   

Mucocin

3-(9-{5-[4-(6-decyl-5-hydroxyoxan-2-yl)-1,4-dihydroxybutyl]oxolan-2-yl}-2-hydroxynonyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Mucocin is found in alcoholic beverages. Mucocin is a constituent of the leaves of Rollinia mucosa (biriba) Constituent of the leaves of Rollinia mucosa (biriba). Mucocin is found in alcoholic beverages and fruits.

   

Annoglaucin

5-methyl-3-{2,8,13-trihydroxy-13-[5-(1-hydroxyundecyl)-[2,2-bioxolane]-5-yl]tridecyl}-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Atemoyacin D is found in fruits. Atemoyacin D is a constituent of the seeds of Annona atemoya (custard apple) Constituent of the seeds of Annona purpurea (soncoya). Annoglaucin is found in beverages and fruits.

   

Sanchinoside B1

2-({5,16-dihydroxy-14-[(2E)-6-hydroxy-6-methylhept-2-en-2-yl]-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-8-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O9 (638.4393602)


Sanchinoside B1 is found in tea. Sanchinoside B1 is a constituent of Panax notoginseng (sanchi). Constituent of Panax notoginseng (sanchi). Sanchinoside B1 is found in tea.

   

Purpurenin

3-(13-{5-[5-(1,6-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}-8,13-dihydroxytridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Purpurenin is found in fruits. Purpurenin is a constituent of the seeds of Annona muricata (soursop) Constituent of the seeds of Annona muricata (soursop). Purpurenin is found in fruits.

   

Rollidecin A

3-(2-hydroxy-9-{5-[5-(1,4,5-trihydroxypentadecyl)oxolan-2-yl]oxolan-2-yl}nonyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Bulladecin is found in fruits. Bulladecin is a constituent of the seeds of Annona atemoya (custard apple)

   

Rollitacin

3-(13-hydroxy-13-{5-[5-(1,5,6-trihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Purpurediolin is found in beverages. Purpurediolin is a constituent of the seeds of Annona purpurea (soncoya) Constituent of the seeds of Annona purpurea (soncoya). Purpurediolin is found in beverages and fruits.

   

Purpureacin 2

5-methyl-3-(2,10,13-trihydroxy-13-{5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Purpureacin 2 is found in alcoholic beverages. Purpureacin 2 is isolated from Rollinia mucosa (biriba) and Annona purpurea. Isolated from Rollinia mucosa (biriba) and Annona purpurea. Purpureacin 2 is found in alcoholic beverages and fruits.

   

Rollimusin

3-(13-{5-[5-(1,5-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}-8,13-dihydroxytridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Rollimusin is found in alcoholic beverages. Rollimusin is a constituent of the unripe fruit of Rollinia mucosa (biriba) Constituent of the unripe fruit of Rollinia mucosa (biriba). Rollimusin is found in alcoholic beverages and fruits.

   

Glabracin A

3-(8-{5-[5-(5,6-dihydroxyhexadecyl)oxolan-2-yl]oxolan-2-yl}-2,8-dihydroxyoctyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Glabracin B is found in alcoholic beverages. Glabracin B is a constituent of the leaves of Annona glabra (pond apple) Constituent of the leaves of Annona glabra (pond apple). Glabracin B is found in alcoholic beverages and fruits.

   

Annonin XIV

3-(13-hydroxy-13-{4-hydroxy-5-[3-hydroxy-5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Annonin XIV is found in fruits. Annonin XIV is a constituent of Annona squamosa (sugar apple) Constituent of Annona squamosa (sugar apple). Annonin XIV is found in fruits.

   

Bullatetrocin

3-(13-hydroxy-13-{5-[5-(1,8,9-trihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Bullatetrocin is a constituent of Asimina triloba (pawpaw) Constituent of Asimina triloba (pawpaw).

   

Muricatin C

3-{13-[5-(1,6-dihydroxypentadecyl)oxolan-2-yl]-2,13-dihydroxy-8-oxotridecyl}-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


Muricatin C is found in fruits. Muricatin C is a constituent of Annona muricata (soursop) Constituent of Annona muricata (soursop). Muricatin C is found in fruits.

   

9-Hydroxyasimicinone

5-(5,11-dihydroxy-11-{5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}undecyl)-3-(2-oxopropyl)oxolan-2-one

C37H66O8 (638.4757436)


9-Hydroxyasimicinone is found in fruits. 9-Hydroxyasimicinone is a constituent of Annona squamosa (sugar apple). Constituent of Annona squamosa (sugar apple). 9-Hydroxyasimicinone is found in fruits.

   

PA(14:1(9Z)/18:4(6Z,9Z,12Z,15Z))

[(2R)-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid

C35H59O8P (638.3947344)


PA(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of stearidonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(18:4(6Z,9Z,12Z,15Z)/14:1(9Z))

[(2R)-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid

C35H59O8P (638.3947344)


PA(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)), in particular, consists of one chain of stearidonic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PG(a-13:0/a-13:0)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-(10-methyldodecanoyloxy)propyl] 10-methyldodecanoate

C32H63O10P (638.4158628)


PG(a-13:0/a-13:0) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(a-13:0/a-13:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11\\% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis.

   

PG(a-13:0/i-13:0)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-(11-methyldodecanoyloxy)propyl] 10-methyldodecanoate

C32H63O10P (638.4158628)


PG(a-13:0/i-13:0) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(a-13:0/i-13:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11\\% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis.

   

PG(i-12:0/i-14:0)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-(10-methylundecanoyloxy)propan-2-yl] 12-methyltridecanoate

C32H63O10P (638.4158628)


PG(i-12:0/i-14:0) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(i-12:0/i-14:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11\\% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis.

   

PG(i-13:0/a-13:0)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-(11-methyldodecanoyloxy)propan-2-yl] 10-methyldodecanoate

C32H63O10P (638.4158628)


PG(i-13:0/a-13:0) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(i-13:0/a-13:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11\\% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis.

   

PG(i-13:0/i-13:0)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-(11-methyldodecanoyloxy)propyl] 11-methyldodecanoate

C32H63O10P (638.4158628)


PG(i-13:0/i-13:0) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(i-13:0/i-13:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11\\% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis.

   

PG(i-14:0/i-12:0)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-(10-methylundecanoyloxy)propyl] 12-methyltridecanoate

C32H63O10P (638.4158628)


PG(i-14:0/i-12:0) is a phosphatidylglycerol - a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(i-14:0/i-12:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11\\% of the total). It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for cardiolipin synthesis.

   

Filipin II

3-hexyl-4,6,8,10,12,14,16,27-octahydroxy-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C35H58O10 (638.4029768)


   

DG(14:0/PGF2alpha/0:0)

(2S)-2-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-hydroxypropyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(14:0/PGF2alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/PGF2alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGF2alpha/14:0/0:0)

(2S)-1-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-hydroxypropan-2-yl tetradecanoic acid

C37H66O8 (638.4757436)


DG(PGF2alpha/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF2alpha/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/0:0/PGF2alpha)

(2R)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-hydroxypropyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(14:0/0:0/PGF2alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGF2alpha/0:0/14:0)

(2S)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-hydroxypropyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(PGF2alpha/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/PGE1/0:0)

(2S)-3-Hydroxy-2-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(14:0/PGE1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/PGE1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGE1/14:0/0:0)

(2S)-1-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propan-2-yl tetradecanoic acid

C37H66O8 (638.4757436)


DG(PGE1/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE1/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/0:0/PGE1)

(2R)-2-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(14:0/0:0/PGE1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGE1/0:0/14:0)

(2S)-2-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(PGE1/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/PGD1/0:0)

(2S)-3-Hydroxy-2-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(14:0/PGD1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/PGD1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGD1/14:0/0:0)

(2S)-1-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propan-2-yl tetradecanoic acid

C37H66O8 (638.4757436)


DG(PGD1/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD1/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/0:0/PGD1)

(2R)-2-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(14:0/0:0/PGD1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGD1/0:0/14:0)

(2S)-2-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl tetradecanoic acid

C37H66O8 (638.4757436)


DG(PGD1/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/5-iso PGF2VI/0:0)

(2S)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropyl hexadecanoate

C37H66O8 (638.4757436)


DG(16:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/16:0/0:0)

(2S)-1-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropan-2-yl hexadecanoic acid

C37H66O8 (638.4757436)


DG(5-iso PGF2VI/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/5-iso PGF2VI)

(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl hexadecanoic acid

C37H66O8 (638.4757436)


DG(16:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/0:0/16:0)

(2S)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl hexadecanoic acid

C37H66O8 (638.4757436)


DG(5-iso PGF2VI/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/PGF2alpha/0:0)

(2S)-2-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-hydroxypropyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(i-14:0/PGF2alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/PGF2alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGF2alpha/i-14:0/0:0)

(2S)-1-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-hydroxypropan-2-yl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(PGF2alpha/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF2alpha/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/PGF2alpha)

(2R)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-hydroxypropyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(i-14:0/0:0/PGF2alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGF2alpha/0:0/i-14:0)

(2S)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-hydroxypropyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(PGF2alpha/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/PGE1/0:0)

(2S)-3-Hydroxy-2-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(i-14:0/PGE1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/PGE1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGE1/i-14:0/0:0)

(2S)-1-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propan-2-yl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(PGE1/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE1/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/PGE1)

(2R)-2-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(i-14:0/0:0/PGE1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGE1/0:0/i-14:0)

(2S)-2-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(PGE1/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/PGD1/0:0)

(2S)-3-Hydroxy-2-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(i-14:0/PGD1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/PGD1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGD1/i-14:0/0:0)

(2S)-1-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propan-2-yl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(PGD1/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD1/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/PGD1)

(2R)-2-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(i-14:0/0:0/PGD1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGD1/0:0/i-14:0)

(2S)-2-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl 12-methyltridecanoic acid

C37H66O8 (638.4757436)


DG(PGD1/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/5-iso PGF2VI/0:0)

(2S)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropyl 14-methylpentadecanoic acid

C37H66O8 (638.4757436)


DG(i-16:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/i-16:0/0:0)

(2S)-1-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropan-2-yl 14-methylpentadecanoic acid

C37H66O8 (638.4757436)


DG(5-iso PGF2VI/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/5-iso PGF2VI)

(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl 14-methylpentadecanoic acid

C37H66O8 (638.4757436)


DG(i-16:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/0:0/i-16:0)

(2S)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl 14-methylpentadecanoic acid

C37H66O8 (638.4757436)


DG(5-iso PGF2VI/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

23-O-beta-D-Glucopyranosyl-25-methyldolichosterone

(2R,4R,5S,7S,15S)-4,5-dihydroxy-14-[(2S,3R,4R)-3-hydroxy-6,6-dimethyl-5-methylidene-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-8-one

C35H58O10 (638.4029768)


23-o-beta-d-glucopyranosyl-25-methyldolichosterone is a member of the class of compounds known as steroidal glycosides. Steroidal glycosides are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. 23-o-beta-d-glucopyranosyl-25-methyldolichosterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 23-o-beta-d-glucopyranosyl-25-methyldolichosterone can be found in common bean, green bean, and yellow wax bean, which makes 23-o-beta-d-glucopyranosyl-25-methyldolichosterone a potential biomarker for the consumption of these food products.

   

23-O-beta-D-Glucopyranosyl-2-epi-25-methyldolichosterone

(2R,4S,5S,7S,15S)-4,5-dihydroxy-14-[(2S,3R,4R)-3-hydroxy-6,6-dimethyl-5-methylidene-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-8-one

C35H58O10 (638.4029768)


23-o-beta-d-glucopyranosyl-2-epi-25-methyldolichosterone is a member of the class of compounds known as steroidal glycosides. Steroidal glycosides are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. 23-o-beta-d-glucopyranosyl-2-epi-25-methyldolichosterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 23-o-beta-d-glucopyranosyl-2-epi-25-methyldolichosterone can be found in common bean, green bean, and yellow wax bean, which makes 23-o-beta-d-glucopyranosyl-2-epi-25-methyldolichosterone a potential biomarker for the consumption of these food products.

   

14-Hydroxy-25-desoxyrollinicin

5-methyl-3-(2,12,13-trihydroxy-13-{5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


14-hydroxy-25-desoxyrollinicin is a member of the class of compounds known as annonaceous acetogenins. Annonaceous acetogenins are waxy derivatives of fatty acids (usually C32 or C34), containing a terminal carboxylic acid combined with a 2-propanol unit at the C-2 position to form a methyl- substituted alpha,beta-unsaturated-gamma-lactone. One of their interesting structural features is a single, adjacent, or nonadjacent tetrahydrofuran (THF) or tetrahydropyran (THP) system with one or two flanking hydroxyl group(s) at the center of a long hydrocarbon chain. 14-hydroxy-25-desoxyrollinicin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 14-hydroxy-25-desoxyrollinicin can be found in custard apple, which makes 14-hydroxy-25-desoxyrollinicin a potential biomarker for the consumption of this food product.

   
   
   
   
   
   
   
   
   
   
   
   

23-O-beta-D-Glucopyranosyl-2-epi-25-methyldolichosterone

23-O-beta-D-Glucopyranosyl-2-epi-25-methyldolichosterone

C35H58O10 (638.4029768)


   

4-Acetylannonacin

4-Acetylannonacin

C37H66O8 (638.4757436)


   
   

23-O-beta-D-Glucopyranosyl-25-methyldolichosterone

23-O-beta-D-Glucopyranosyl-25-methyldolichosterone

C35H58O10 (638.4029768)


   

10-Hydroxy-asimicin

(+)-10-Hydroxy-asimicin

C37H66O8 (638.4757436)


   

teikagenin-3-O-beta-D-digitalosyl-20-O-beta-D-oleandroside|teikaside A-Ib

teikagenin-3-O-beta-D-digitalosyl-20-O-beta-D-oleandroside|teikaside A-Ib

C35H58O10 (638.4029768)


   

(2,4-trans)-28-hydroxybullatacinone|28-hydroxybullatacinone

(2,4-trans)-28-hydroxybullatacinone|28-hydroxybullatacinone

C37H66O8 (638.4757436)


   

actinostemmoside A

actinostemmoside A

C36H62O9 (638.4393602)


   
   

31-hydroxybullatacin

31-hydroxybullatacin

C37H66O8 (638.4757436)


   
   
   

32-hydroxybullatacin

32-hydroxybullatacin

C37H66O8 (638.4757436)


   
   

20(S),24(R)-epoxydammaran-3beta,11alpha,25-triol 3-O-beta-D-glucopyranoside

20(S),24(R)-epoxydammaran-3beta,11alpha,25-triol 3-O-beta-D-glucopyranoside

C36H62O9 (638.4393602)


   

(20S)-12beta,16beta-trihydroxydammar-24-ene-3beta-O-D-glucopyranoside|(20S)-12??,16??-Trihydroxydammar-24-ene-3??-O-??-glucopyranoside

(20S)-12beta,16beta-trihydroxydammar-24-ene-3beta-O-D-glucopyranoside|(20S)-12??,16??-Trihydroxydammar-24-ene-3??-O-??-glucopyranoside

C36H62O9 (638.4393602)


   
   

Actinostemmoside B

Actinostemmoside B

C36H62O9 (638.4393602)


   
   

(1alpha,3beta,24R)-1,24,25-trihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-28-oic acid|(1alpha,3beta,24R)-1,3,24,25-tetrahydroxycycloartan-28-oic acid 3-(beta-D-xylopyranoside)|nerviside E

(1alpha,3beta,24R)-1,24,25-trihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-28-oic acid|(1alpha,3beta,24R)-1,3,24,25-tetrahydroxycycloartan-28-oic acid 3-(beta-D-xylopyranoside)|nerviside E

C35H58O10 (638.4029768)


   

3beta,14alpha,15alpha,21alpha-tetrahydroxyserrat-14-en-21-acetyl-3-(4-hydroxybenzoate)

3beta,14alpha,15alpha,21alpha-tetrahydroxyserrat-14-en-21-acetyl-3-(4-hydroxybenzoate)

C39H58O7 (638.4182318000001)


   

(20SR,24RS)-epoxy-9,19-cyclolanostane-3beta,12alpha,16beta,18, 25-pentaol-3-O-beta-D-xylopyranoside

(20SR,24RS)-epoxy-9,19-cyclolanostane-3beta,12alpha,16beta,18, 25-pentaol-3-O-beta-D-xylopyranoside

C35H58O10 (638.4029768)


   

3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-8(9),24(28)Z-diene-6beta,7alpha,16beta,29-tetrol

3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-8(9),24(28)Z-diene-6beta,7alpha,16beta,29-tetrol

C35H58O10 (638.4029768)


   

21beta,24,29-trihydroxyserrat-14-en-3beta-yl dihydrocaffeate|lycophlegmarinol B

21beta,24,29-trihydroxyserrat-14-en-3beta-yl dihydrocaffeate|lycophlegmarinol B

C39H58O7 (638.4182318000001)


   

3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-7,24(28)Z-diene-6beta,9alpha,16beta,29-tetrol

3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-7,24(28)Z-diene-6beta,9alpha,16beta,29-tetrol

C35H58O10 (638.4029768)


   
   

3-O-beta-D-glucopyranosyl-20(S)-protopanaxatriol

3-O-beta-D-glucopyranosyl-20(S)-protopanaxatriol

C36H62O9 (638.4393602)


   
   
   

30-hydroxybullatacin

30-hydroxybullatacin

C37H66O8 (638.4757436)


   
   
   
   

3beta-[{4,6-di-O-acetyl-2,3-dideoxy-alpha-D-erythro-hex-2-enopyranosyl}oxy]lup-12-ene(18beta,19beta)

3beta-[{4,6-di-O-acetyl-2,3-dideoxy-alpha-D-erythro-hex-2-enopyranosyl}oxy]lup-12-ene(18beta,19beta)

C40H62O6 (638.4546152)


   
   
   
   

Ginsenoside F1

2-(hydroxymethyl)-6-[(6-methyl-2-{5,8,16-trihydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}hept-5-en-2-yl)oxy]oxane-3,4,5-triol

C36H62O9 (638.4393602)


Annotation level-1 Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity. Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity.

   

Annonin XIV

3-(13-hydroxy-13-{4-hydroxy-5-[3-hydroxy-5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Kizuta saponin K7

Kizuta saponin K7

C36H62O9 (638.4393602)


   

3-O-alpha-L-rhamnopyranoside-24R-cycloartan-1alpha,3beta,7beta,24,25-pentaol|cyclomacroside C

3-O-alpha-L-rhamnopyranoside-24R-cycloartan-1alpha,3beta,7beta,24,25-pentaol|cyclomacroside C

C36H62O9 (638.4393602)


   
   

Chikusetsusaponin-L(10)

Chikusetsusaponin-L(10)

C36H62O9 (638.4393602)


   

Mogroside I A1

(2S,3R,4S,5S,6R)-2-[(3R,6R)-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylheptan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O9 (638.4393602)


   

ginsenoside Rh1

ginsenoside Rh1

C36H62O9 (638.4393602)


Annotation level-1 Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.

   

PG(14:0/12:0)

1-tetradecanoyl-2-dodecanoyl-glycero-3-phospho-(1-sn-glycerol)

C32H63O10P (638.4158628)


   

PG(13:0/13:0)

1,2-ditridecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)

C32H63O10P (638.4158628)


   

PG(12:0/14:0)

1-dodecanoyl-2-tetradecanoyl-glycero-3-phospho-(1-sn-glycerol)

C32H63O10P (638.4158628)


   

PA(12:0/20:5(5Z,8Z,11Z,14Z,17Z))

1-dodecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate

C35H59O8P (638.3947344)


   

PA(14:1(9Z)/18:4(6Z,9Z,12Z,15Z))

1-(9Z-tetradecenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate

C35H59O8P (638.3947344)


   

PA(18:4(6Z,9Z,12Z,15Z)/14:1(9Z))

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C35H59O8P (638.3947344)


   

PA(20:5(5Z,8Z,11Z,14Z,17Z)/12:0)

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-dodecanoyl-glycero-3-phosphate

C35H59O8P (638.3947344)


   

annoglaucin

5-methyl-3-(2,8,13-trihydroxy-13-{5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Muricatin C

3-{13-[5-(1,6-dihydroxypentadecyl)oxolan-2-yl]-2,13-dihydroxy-8-oxotridecyl}-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Rollidecin A

3-(2-hydroxy-9-{5-[5-(1,4,5-trihydroxypentadecyl)oxolan-2-yl]oxolan-2-yl}nonyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Bullatetrocin

3-(13-hydroxy-13-{5-[5-(1,8,9-trihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Rollitacin

3-(13-hydroxy-13-{5-[5-(1,5,6-trihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Mucocin

3-(9-{5-[4-(6-decyl-5-hydroxyoxan-2-yl)-1,4-dihydroxybutyl]oxolan-2-yl}-2-hydroxynonyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

glabracin A

3-(8-{5-[5-(5,6-dihydroxyhexadecyl)oxolan-2-yl]oxolan-2-yl}-2,8-dihydroxyoctyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Purpurenin

3-(13-{5-[5-(1,6-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}-8,13-dihydroxytridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

12,15-cis-Squamostatin A

3-[9-(5-{4-[5-(1,5-dihydroxyundecyl)oxolan-2-yl]-1,4-dihydroxybutyl}oxolan-2-yl)nonyl]-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

Rollimusin

3-(13-{5-[5-(1,5-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}-8,13-dihydroxytridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

20,23-cis-Bullatalicinone

5-[7-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)heptyl]-3-(2-oxopropyl)oxolan-2-one

C37H66O8 (638.4757436)


   

27-hydroxybullatacin

3-(13-{5-[5-(1,4-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl}-2,13-dihydroxytridecyl)-5-methyl-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

9-Hydroxyasimicinone

5-(5,11-dihydroxy-11-{5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}undecyl)-3-(2-oxopropyl)oxolan-2-one

C37H66O8 (638.4757436)


   

Sanchinoside B1

2-({5,16-dihydroxy-14-[(2E)-6-hydroxy-6-methylhept-2-en-2-yl]-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-8-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O9 (638.4393602)


   

Sanchinoside B2

2-{[5,16-dihydroxy-14-(2-hydroxy-6-methylhept-5-en-2-yl)-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O9 (638.4393602)


(20R)-Ginsenoside Rh1, the R isomer of Ginsenoside Rh1 isolated from Panax Ginseng, inhibits the thrombin-induced conversion of fibrinogen to fibrin[1]. (20R)-Ginsenoside Rh1, the R isomer of Ginsenoside Rh1 isolated from Panax Ginseng, inhibits the thrombin-induced conversion of fibrinogen to fibrin[1]. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β. Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.

   

12-Hydroxybullatacin

5-methyl-3-(2,10,13-trihydroxy-13-{5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl}tridecyl)-2,5-dihydrofuran-2-one

C37H66O8 (638.4757436)


   

PG 26:0

1-dodecanoyl-2-tetradecanoyl-glycero-3-phospho-(1-sn-glycerol)

C32H63O10P (638.4158628)


   

PA 32:5

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C35H59O8P (638.3947344)


   
   
   
   
   
   
   
   
   

(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one

(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one

C39H66O3Si2 (638.4550246)


   

Hexamethylene bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

Hexamethylene bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

C40H62O6 (638.4546152)


   

calcium(2+) 12-hydroxyoctadecanoate

calcium(2+) 12-hydroxyoctadecanoate

C36H70CaO6 (638.479803)


   

5-[7-[5-[1,4-Dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl]oxolan-2-yl]heptyl]-3-(2-oxopropyl)oxolan-2-one

5-[7-[5-[1,4-Dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl]oxolan-2-yl]heptyl]-3-(2-oxopropyl)oxolan-2-one

C37H66O8 (638.4757436)


   

4-[13-[5-[5-(1,4-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl]-2,13-dihydroxytridecyl]-2-methyl-2H-furan-5-one

4-[13-[5-[5-(1,4-dihydroxyundecyl)oxolan-2-yl]oxolan-2-yl]-2,13-dihydroxytridecyl]-2-methyl-2H-furan-5-one

C37H66O8 (638.4757436)


   

(17Z,19E,21E,23E,25E)-3-hexyl-4,6,8,10,12,14,16,27-octahydroxy-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

(17Z,19E,21E,23E,25E)-3-hexyl-4,6,8,10,12,14,16,27-octahydroxy-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C35H58O10 (638.4029768)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

   

14-Hydroxy-25-desoxyrollinicin

14-Hydroxy-25-desoxyrollinicin

C37H66O8 (638.4757436)


   

DG(14:0/PGF2alpha/0:0)

DG(14:0/PGF2alpha/0:0)

C37H66O8 (638.4757436)


   

DG(PGF2alpha/14:0/0:0)

DG(PGF2alpha/14:0/0:0)

C37H66O8 (638.4757436)


   

DG(14:0/0:0/PGF2alpha)

DG(14:0/0:0/PGF2alpha)

C37H66O8 (638.4757436)


   

DG(PGF2alpha/0:0/14:0)

DG(PGF2alpha/0:0/14:0)

C37H66O8 (638.4757436)


   

DG(i-14:0/PGF2alpha/0:0)

DG(i-14:0/PGF2alpha/0:0)

C37H66O8 (638.4757436)


   

DG(PGF2alpha/i-14:0/0:0)

DG(PGF2alpha/i-14:0/0:0)

C37H66O8 (638.4757436)


   

DG(i-14:0/0:0/PGF2alpha)

DG(i-14:0/0:0/PGF2alpha)

C37H66O8 (638.4757436)


   

DG(PGF2alpha/0:0/i-14:0)

DG(PGF2alpha/0:0/i-14:0)

C37H66O8 (638.4757436)


   

DG(14:0/PGE1/0:0)

DG(14:0/PGE1/0:0)

C37H66O8 (638.4757436)


   

DG(PGE1/14:0/0:0)

DG(PGE1/14:0/0:0)

C37H66O8 (638.4757436)


   

DG(14:0/0:0/PGE1)

DG(14:0/0:0/PGE1)

C37H66O8 (638.4757436)


   

DG(PGE1/0:0/14:0)

DG(PGE1/0:0/14:0)

C37H66O8 (638.4757436)


   

DG(14:0/PGD1/0:0)

DG(14:0/PGD1/0:0)

C37H66O8 (638.4757436)


   

DG(PGD1/14:0/0:0)

DG(PGD1/14:0/0:0)

C37H66O8 (638.4757436)


   

DG(14:0/0:0/PGD1)

DG(14:0/0:0/PGD1)

C37H66O8 (638.4757436)


   

DG(PGD1/0:0/14:0)

DG(PGD1/0:0/14:0)

C37H66O8 (638.4757436)


   

DG(i-14:0/PGE1/0:0)

DG(i-14:0/PGE1/0:0)

C37H66O8 (638.4757436)


   

DG(PGE1/i-14:0/0:0)

DG(PGE1/i-14:0/0:0)

C37H66O8 (638.4757436)


   

DG(i-14:0/0:0/PGE1)

DG(i-14:0/0:0/PGE1)

C37H66O8 (638.4757436)


   

DG(PGE1/0:0/i-14:0)

DG(PGE1/0:0/i-14:0)

C37H66O8 (638.4757436)


   

DG(i-14:0/PGD1/0:0)

DG(i-14:0/PGD1/0:0)

C37H66O8 (638.4757436)


   

DG(PGD1/i-14:0/0:0)

DG(PGD1/i-14:0/0:0)

C37H66O8 (638.4757436)


   

DG(i-14:0/0:0/PGD1)

DG(i-14:0/0:0/PGD1)

C37H66O8 (638.4757436)


   

DG(PGD1/0:0/i-14:0)

DG(PGD1/0:0/i-14:0)

C37H66O8 (638.4757436)


   

DG(16:0/5-iso PGF2VI/0:0)

DG(16:0/5-iso PGF2VI/0:0)

C37H66O8 (638.4757436)


   

DG(5-iso PGF2VI/16:0/0:0)

DG(5-iso PGF2VI/16:0/0:0)

C37H66O8 (638.4757436)


   

DG(16:0/0:0/5-iso PGF2VI)

DG(16:0/0:0/5-iso PGF2VI)

C37H66O8 (638.4757436)


   

DG(5-iso PGF2VI/0:0/16:0)

DG(5-iso PGF2VI/0:0/16:0)

C37H66O8 (638.4757436)


   

DG(i-16:0/5-iso PGF2VI/0:0)

DG(i-16:0/5-iso PGF2VI/0:0)

C37H66O8 (638.4757436)


   

DG(5-iso PGF2VI/i-16:0/0:0)

DG(5-iso PGF2VI/i-16:0/0:0)

C37H66O8 (638.4757436)


   

DG(i-16:0/0:0/5-iso PGF2VI)

DG(i-16:0/0:0/5-iso PGF2VI)

C37H66O8 (638.4757436)


   

DG(5-iso PGF2VI/0:0/i-16:0)

DG(5-iso PGF2VI/0:0/i-16:0)

C37H66O8 (638.4757436)


   
   

Annosquatin-II, (rel)-

Annosquatin-II, (rel)-

C37H66O8 (638.4757436)


A natural product found in Annona squamosa.

   

Annosquatin-I, (rel)-

Annosquatin-I, (rel)-

C37H66O8 (638.4757436)


A natural product found in Annona squamosa.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] heptacosanoate

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] heptacosanoate

C33H67O9P (638.4522462)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] undecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] undecanoate

C33H67O9P (638.4522462)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] tetradecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] tetradecanoate

C33H67O9P (638.4522462)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] dodecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] dodecanoate

C33H67O9P (638.4522462)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] decanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] decanoate

C33H67O9P (638.4522462)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] pentadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] pentadecanoate

C33H67O9P (638.4522462)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] tridecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] tridecanoate

C33H67O9P (638.4522462)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] hexadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] hexadecanoate

C33H67O9P (638.4522462)


   

[1-Decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate

[1-Decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate

C33H67O9P (638.4522462)


   

[3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[(4E,8E,12E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   
   
   

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl (Z)-tridec-8-enoate

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl (Z)-tridec-8-enoate

C40H62O6 (638.4546152)


   
   
   
   

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C35H58O10 (638.4029768)


   

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C35H58O10 (638.4029768)


   

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C35H58O10 (638.4029768)


   

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C35H58O10 (638.4029768)


   

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C35H58O10 (638.4029768)


   

[2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H63N2O6P (638.4423508)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tricosanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tricosanoate

C32H63O10P (638.4158628)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] henicosanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] henicosanoate

C32H63O10P (638.4158628)


   

[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetracosanoate

[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetracosanoate

C32H63O10P (638.4158628)


   

[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] docosanoate

[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] docosanoate

C32H63O10P (638.4158628)


   

[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] icosanoate

[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] icosanoate

C32H63O10P (638.4158628)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] octadecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] octadecanoate

C32H63O10P (638.4158628)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] heptadecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] heptadecanoate

C32H63O10P (638.4158628)


   

[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] nonadecanoate

[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] nonadecanoate

C32H63O10P (638.4158628)


   

[1-[(2-Decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] hexadecanoate

[1-[(2-Decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] hexadecanoate

C32H63O10P (638.4158628)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] pentadecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] pentadecanoate

C32H63O10P (638.4158628)


   

[1-[(2-Dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetradecanoate

[1-[(2-Dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetradecanoate

C32H63O10P (638.4158628)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tridecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tridecanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] heptadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] heptadecanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] henicosanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] henicosanoate

C32H63O10P (638.4158628)


   

[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] tetracosanoate

[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] tetracosanoate

C32H63O10P (638.4158628)


   

[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] docosanoate

[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] docosanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] nonadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] nonadecanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] icosanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] icosanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] octadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] octadecanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] tricosanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] tricosanoate

C32H63O10P (638.4158628)


   

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] tridecanoate

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] tridecanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] tetradecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] tetradecanoate

C32H63O10P (638.4158628)


   

[1-Decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] hexadecanoate

[1-Decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] hexadecanoate

C32H63O10P (638.4158628)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

C32H63O10P (638.4158628)


   

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (Z)-hexadec-9-enoate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (Z)-hexadec-9-enoate

C35H59O8P (638.3947344)


   

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C35H59O8P (638.3947344)


   

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C35H59O8P (638.3947344)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H59O8P (638.3947344)


   

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C35H59O8P (638.3947344)


   

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C35H59O8P (638.3947344)


   

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] hexadecanoate

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] hexadecanoate

C32H63O10P (638.4158628)


   

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

C32H63O10P (638.4158628)


   

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] pentadecanoate

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] pentadecanoate

C32H63O10P (638.4158628)


   

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate

C35H59O8P (638.3947344)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

C35H59O8P (638.3947344)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] hexadecanoate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] hexadecanoate

C35H59O8P (638.3947344)


   

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C35H59O8P (638.3947344)


   

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C35H59O8P (638.3947344)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

C35H59O8P (638.3947344)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C35H59O8P (638.3947344)


   

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C35H59O8P (638.3947344)


   

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C35H59O8P (638.3947344)


   

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C35H59O8P (638.3947344)


   

[1-[(E)-dec-4-enoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[1-[(E)-dec-4-enoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H58O10 (638.4029768)


   

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H59O8P (638.3947344)


   

[1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C35H58O10 (638.4029768)


   

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] hexadecanoate

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] hexadecanoate

C32H63O10P (638.4158628)


   

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

C35H59O8P (638.3947344)


   

[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H58O10 (638.4029768)


   

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C35H59O8P (638.3947344)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C35H59O8P (638.3947344)


   

2-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H61NO7P+ (638.4185425999999)


   

2-[carboxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octanoyloxypropoxy]methoxy]ethyl-trimethylazanium

2-[carboxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C36H64NO8+ (638.4631684000001)


   

2-[carboxy-[3-decanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

2-[carboxy-[3-decanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C36H64NO8+ (638.4631684000001)


   

2-[hydroxy-[2-propanoyloxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-propanoyloxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H61NO7P+ (638.4185425999999)


   

Ginsenoside

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol

C36H62O9 (638.4393602)


Ginsenoside F1 is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite and an apoptosis inhibitor. It is a 12beta-hydroxy steroid, a 3beta-hydroxy steroid, a beta-D-glucoside, a ginsenoside, a tetracyclic triterpenoid, a 6alpha-hydroxy steroid and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane. Ginsenoside F1 is a natural product found in Panax ginseng, Panax notoginseng, and Gynostemma yixingense with data available. A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity. Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity.

   
   

squamostatin-A

squamostatin-A

C37H66O8 (638.4757436)


A natural product found in Annona squamosa.

   

TG(37:7)

TG(6:0_11:3_20:4)

C40H62O6 (638.4546152)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 18:6/O-25:7

FAHFA 18:6/O-25:7

C43H58O4 (638.4334868)


   

FAHFA 19:6/O-24:7

FAHFA 19:6/O-24:7

C43H58O4 (638.4334868)


   

FAHFA 20:6/O-23:7

FAHFA 20:6/O-23:7

C43H58O4 (638.4334868)


   

FAHFA 21:6/O-22:7

FAHFA 21:6/O-22:7

C43H58O4 (638.4334868)


   

FAHFA 21:7/O-22:6

FAHFA 21:7/O-22:6

C43H58O4 (638.4334868)


   

FAHFA 22:6/O-21:7

FAHFA 22:6/O-21:7

C43H58O4 (638.4334868)


   

FAHFA 22:7/O-21:6

FAHFA 22:7/O-21:6

C43H58O4 (638.4334868)


   

FAHFA 23:7/O-20:6

FAHFA 23:7/O-20:6

C43H58O4 (638.4334868)


   

FAHFA 24:7/O-19:6

FAHFA 24:7/O-19:6

C43H58O4 (638.4334868)


   

FAHFA 25:7/O-18:6

FAHFA 25:7/O-18:6

C43H58O4 (638.4334868)